1. Vinik AI, Mitchell BD, Leichter SB, Wagner AL, O'Brian JT, Georges LP: Epidemiology of the Complications of Diabetes. In Diabetes: Clinical Science in Practice. Leslie RDG, Robbins DC, Eds. Cambridge, United Kingdom, Cambridge University Press, 1995, p. 221-287
2. Holzer SE, Camerota A, Martens L, Cuerdon T, Crystal P, Zagari M: Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther 20:169-181, 1998
3. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW: Assessment and management of foot disease in patients with diabetes. N Engl J Med 331:854-860, 1994
4. Herman WH, Kennedy L: Underdiagnosis of peripheral neuropathy in type 2 diabetes. Diabetes Care 28:1480-1481, 2005
5. Young MJ, Boulton AJM, MacLeod AF, Williams DRR, Sonksen PH: A multicenter study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36:1-5, 1993
6. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, O'Brien PC, Melton III LJ: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology 43:817-824, 1993
7. Vinik A: Diabetic Neuropathy: Pathogenesis and Therapy. Am J Med 107 (2B):17S-26S, 1999
8. Armstrong DG, Lavery LA, Harkless LB: Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 21:855-859, 1998
9. Vinik, E., Hayes, R., Oglesby, A., Bastyr, E., Barlow, P., Ford-Molvik, S., and Vinik, A. The Development and validation of the Norfolk QOL-DN a New Measure of patients' Perception of the Effects of Diabetes and Diabetic Neuropathy. Diabetes Technol.Ther 7 (3), 497-508. 2005.
10. Levitt NS, Stansberry KB, Wychanck S, Vinik AI: Natural progression of autonomic neuropathy and autonomic function tests in a cohort of IDDM. Diabetes Care 19:751-754, 1996
11. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA: Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 10:820-824, 1993
12. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM: Diabetic somatic neuropathies. Diabetes Care 27:1458-1486, 2004
13. Dyck, P. J. Severity and staging of diabetic polyneuropathy. Textbook of Diabetic Neuropathy , 170-175. 2003. Thieme, Stuttgart.
14. Thomas PK: Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes 46 Suppl 2:S54-S57, 1997
15. Vinik A, Ullal J, Parson HK, Casellini CM: Diabetic neuropathies: clinical manifestations and current treatment options. Nat Clin Pract Endocrinol Metab 2:269-281, 2006
16. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D: Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28:956-962, 2005
17. Vinik AI, Mehrabyan A: Diabetic neuropathies. Med Clin North Am 88:947-99, xi, 2004
18. Watkins PJ: Progression of diabetic autonomic neuropathy. Diabet Med 10 [Suppl 2]:77S-78S, 1993
19. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
20. DCCT Research Group: The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122:561-568, 1995
21. Ziegler D, Cicmir I, Mayer P, Wiefels K, Gries FA: Somatic and autonomic nerve function during the first year after diagnosis of type 1 (insulin-dependent) diabetes. Diabetes Res 7:123-127, 1988
22. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M: Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333:89-94, 1995
23. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ, O'Brien PC, Litchy WJ, Windebank AJ, Smith BE, Low PA: The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 41:799-807, 1991
24. Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G, Bastyr EJ, III, Wolka AM, Vinik AI: A 6-Month, Randomized, Double-Masked, Placebo-Controlled Study Evaluating the Effects of the Protein Kinase C-{beta} Inhibitor Ruboxistaurin on Skin Microvascular Blood Flow and Other Measures of Diabetic Peripheral Neuropathy. Diabetes Care 30:896-902, 2007
25. Pittenger G, Simmons K, Anandacoomaraswamy D, rice A, Barlow P, Vinik A: Topiramate improves intraepidermal nerve fiber morphology and quantitative neuropathy measures in diabetic neuropathy patients (Abstract). J.Peripher.Nerve System 10 (Suppl 1) : 2005
26. Pittenger GL, Ray M, Burcus NI, McNulty P, Basta B, Vinik AI: Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care 27:1974-1979, 2004
27. Sinnreich M, Taylor BV, Dyck PJ: Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist 11:63-79, 2005
28. Vinik AI: Advances in diabetes for the millennium: new treatments for diabetic neuropathies. MedGenMed 6:13, 2004
29. Vinik AI, Holland MT, LeBeau JM, Liuzzi FJ, Stansberry KB, Colen LB: Diabetic neuropathies. Diabetes Care 15:1926-1975, 1992
30. Vinik A, Mehrabyan A, Colen L, Boulton A: Focal entrapment neuropathies in diabetes. Diabetes Care 27:1783-1788, 2004
31. Wilbourn, A. J. Diabetic entrapment and compression neuropathies. Dyck PJ, Thomas PK (EDS) Diabetic Neuropathy , 481-508. 1999. Philadelphia, Saunders.
32. Watanabe K, Hagura R, Akanuma Y, Takasu T, Kajinuma H, Kuzuya N, Irie M: Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract 10:19-27, 1990
33. Perkins, B., Olaleye, D., and Bril, V. Carpal Tunnel Syndrome in Patients with Diabetic Polyneuropathy. Diabetes Care 25, 565-569. 2002.
34. Dawson DM: Entrapment neuropathies of the upper extremities. N Engl J Med 329:2013-2018, 1993
35. Casellini C, Barlow P, rice A, Casey M, Simmons K, Pittenger G, Bastyr E, Vinik A: Effect of Ruboxistaurin (RBX) on Quantitative Measures of Diabetic Peripheral Neuropathy (DPN) (Abstract). Diabetes 791-P : 2006
36. Llewelyn JG, Thomas PK, King RH: Epineurial microvasculitis in proximal diabetic neuropathy. J Neurol 245:159-165, 1998
37. James, P., Dyck, B., and Windenbank, A. Diabetic and Nondiabetic Lumbosacral Radiculoplexus Neuropathy: New Insights into Pathophysiology. Muscle & Nerve 25, 477-491. 2002.
38. Vinik AI, Pittenger GL, Milicevic Z, Cuca J: Autoimmune Mechanisms in the Pathogenesis of Diabetic Neuropathy. In Molecular Mechanisms of Endocrine and Organ Specific Autoimmunity. 1st ed. Eisenbarth RG, Ed. Georgetown, Landes Company, 1998, p. 217-251
39. Steck AJ, Kappos L: Gangliosides and autoimmune neuropathies: classification and clinical aspects of autoimmune neuropathies. J Neurol Neurosurg Psychiatry 57 [Suppl]:26-28, 1994
40. Said G, Goulon-Goreau C, Lacroix C, Moulonguet A: Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 35:559-569, 1994
41. Sander HW, Chokroverty S: Diabetic amyotrophy: current concepts. Semin Neurol 16:173-178, 1996
42. Krendel DA, Costigan DA, Hopkins LC: Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 52:1053-1061, 1995
43. Britland ST, Young RJ, Sharma AK, Clarke BF: Acute and remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fibre pathology. Pain 48:361-370, 1992
44. Sharma, K., Cross, J., Farronay, O., Ayyar, D., Sheber, R., and Bradley, W. Demyelinating neuropathy in diabetes mellitus. Arch Neurol 59, 758-765. 2002.
45. Krendel DA, Zacharias A, Younger DS: Autoimmune diabetic neuropathy. Neurol Clin 15:959-971, 1997
46. Milicevic Z, Newlon PG, Pittenger GL, Stansberry KB, Vinik AI: Anti-ganglioside GM1 antibody and distal symmetric "diabetic polyneuropathy" with dominant motor features. Diabetologia 40:1364-1365, 1997
47. Ayyar DR, Sharma KR: Chronic inflammatory demyelinating polyradiculoneuropathy in diabetes mellitus. Curr Diab Rep 4:409-412, 2004
48. Barada A, Reljanovic M, Milicevic Z, Ljubic S, Car N, Benko B, Vinik AI, Metelko Z: Proximal Diabetic Neuropathy-Response To Immunotherapy (Abstract). Diabetes 48 [Suppl 1]:A148, 1999
49. Boulton AJ, Malik RA: Diabetic neuropathy. Med Clin North Am 82:909-929, 1998
50. Bird SJ, Brown MJ: The clinical spectrum of diabetic neuropathy. Semin Neurol 16:115-122, 1996
51. Oyibo SO, Prasad YD, Jackson NJ, Jude EB, Boulton AJ: The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 19:870-873, 2002
52. Tesfaye S, Malik R, Harris N, Jakubowski JJ, Mody C, Rennie IG, Ward JD: Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 39:329-335, 1996
53. Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J: The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 46:491-499, 1983
54. Harris M, Eastman R, Cowie C: Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 16:1446-1452, 1993
55. Singleton JR, Smith AG, Bromberg MB: Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 24:1225-1228, 2001
56. Singleton JR, Smith AG, Bromberg MB: Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24:1448-1453, 2001
57. Novella SP, Inzucchi SE, Goldstein JM: The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 24:1229-1231, 2001
58. Sumner, C., Sheth, S., Griffin, J., Cornblath, D., and Polydefkis, M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology , 108-111. 2003.
59. Dyck PJ, Lais A, Karnes JL, O'Brien P, Rizza R: Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 19:425-439, 1986
60. Cavanagh PR, Simoneau GG, Ulbrecht JS: Ulceration, unsteadiness, and uncertainty: the biomechanical consequences of diabetes mellitus. J Biomech 26 Suppl 1:23-40:23-40, 1993
61. Katoulis EC, Ebdon-Parry M, Lanshammar H, Vileikyte L, Kulkarni J, Boulton AJ: Gait abnormalities in diabetic neuropathy. Diabetes Care 20:1904-1907, 1997
62. Vinik, A., Erbas, T., Stansberry, K. B., and Pittenger, G. Small fiber neuropathy and neurovascular disturbances in diabetes mellitus. Exp Clin Endocrinol Diabetes 109(Suppl 2), S451-S473. 2001.
63. Bourcier ME, Ullal J, Parson HK, Dublin CB, Witherspoon CA, Ward SA, Vinik AI: Diabetic peripheral neuropathy: how reliable is a homemade 1-g monofilament for screening? J Fam Pract 55:505-508, 2006
64. Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ: Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 13:63-67, 1991
65. Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG: Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med 158:289-292, 1998
66. Vinik AI, Suwanwalaikorn S, Stansberry KB, Holland MT, McNitt PM, Colen LE: Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve 18:574-584, 1995
67. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, Ryder CH, Torkington R, Van Ross ER, Whalley AM, Widdows P, Williamson S, Boulton AJ: The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19:377-384, 2002
68. Dyck PJ, Melton LJ, III, O'Brien PC, Service FJ: Approaches to improve epidemiological studies of diabetic neuropathy: insights from the Rochester Diabetic Neuropathy Study. Diabetes 46 Suppl 2:S5-S8, 1997
69. Dyck PJ, Dyck PJ, Larson TS, O'Brien PC, Velosa JA: Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care 23:510-517, 2000
70. Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ: Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 21:1071-1075, 1998
71. Yarnitsky D, Sprecher E: Thermal testing: normative data and repeatability for various test algorithms. J Neurol Sci 125:39-45, 1994
72. Shy, M. E., Frohman, E. M., So, Y., Arezzo, J. C., Cornblath, D. C., Giuliani, M. J., and the subcommittee of the American Academy of Neurology. Quantitative sensory testing. Neurology 602, 898-906. 2003.
73. Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology. Diabetes Care 11:592-597, 1988
74. Diabetic polyneuropathy in controlled clinical trials: Consensus Report of the Peripheral Nerve Society. Ann Neurol 38:478-482, 1995
75. Kennedy WR, Wendelschafer-Crabb G, Johnson T: Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47:1042-1048, 1996
76. Polydefkis M, Hauer P, Griffin JW, McArthur JC: Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol Ther 3:23-28, 2001
77. Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, Smith S, Hamwi J, Pollari D, Bixby B, Howard J, Singleton JR: Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 29:1294-1299, 2006
78. Vileikyte L, Peyrot M, Bundy C, Rubin RR, Leventhal H, Mora P, Shaw JE, Baker P, Boulton AJ: The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument. Diabetes Care 26:2549-2555, 2003
79. Cameron, N. E., Eaton, S. E. M., Cotter, M. A., and Tesfaye, S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44, 1973-1988. 2001.
80. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. [published erratum appears in BMJ 1999 Jan 2;318(7175):29] . BMJ 317:703-713, 1998
81. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
82. Gaede P, Vedel P, Larsen N, Jensen G, Parving H, Pedersen O: Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes. N Engl J Med383-393, 2003
83. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH: Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341-350, 2005
84. Kamiya H, Zhang W, Sima AA: C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes. Ann Neurol 56:827-835, 2004
85. Stevens MJ, Zhang W, Li F, Sima AA: C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats. Am J Physiol Endocrinol Metab 287:E497-E505, 2004
86. Ekberg K, Brismar T, Johansson BL, Jonsson B, Lindstrom P, Wahren J: Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes. Diabetes 52:536-541, 2003
87. Johansson BL, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, Wahren J: C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 39:687-695, 1996
88. Ekberg K, Brismar T, Johansson BL, Lindstrom P, Juntti-Berggren L, Norrby A, Berne C, Arnqvist HJ, Bolinder J, Wahren J: C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy. Diabetes Care 30:71-76, 2007
89. Ziegler D, Sohr CG, Nourooz-Zadeh J: Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 27:2178-2183, 2004
90. Miyauchi Y, Shikama H, Takasu T, Okamiya H, Umeda M, Hirasaki E, Ohhata I, Nakayama H, Nakagawa S: Slowing of peripheral motor nerve conduction was ameliorated by aminoguanidine in streptozocin-induced diabetic rats. Eur J Endocrinol 134:467-473, 1996
91. Haupt E, Ledermann H, Kopcke W: Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther 43:71-77, 2005
92. Stracke H, Lindemann A, Federlin K: A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy. Exp Clin Endocrinol Diabetes 104:311-316, 1996
93. Greene DA, Arezzo JC, Brown MB: Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group. Neurology 53:580-591, 1999
94. Hotta, N., Toyota, T., Matsuoka, K., Shigeta, Y., Kikkawa, R., Kaneko, T., Takahashi, A., Sugimura, K., Koike, Y., Ishii, J., Sakamoto, N., and The, S. N. K. Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for diabetic Peripheral Neuropathy. Diabetes Care 24, 1776-1782. 2001.
95. Hotta N, Shigeta Y, Sakamoto N: Long-term Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: A 3-y Multicenter Comparative Study, ARI-Diabetes Complications Trial (ADCT) (Abstract). Diabetes 54 :A213, 2005
96. Bril V, Buchanan RA: Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy. Diabetes Care 29:68-72, 2006
97. Keen H, Payan J, Allawi J, Walker J, Jamal GA, Weir AI, Henderson LM, Bissessar EA, Watkins PJ, Sampson M, Gale EA, Scarpello J, Boddie HG, Hardy KJ, Thomas PK, Misra P, Halonen JP: Treatment of Diabetic Neuropathy with - Linolenic Acid. Diabetes Care 16:8-15, 1993
98. Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, Low PA, Nehrdich D, Novosadova M, O'Brien PC, Reljanovic M, Samigullin R, Schuette K, Strokov I, Tritschler HJ, Wessel K, Yakhno N, Ziegler D: The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 26:770-776, 2003
99. Ruhnau, K. J., Meissner, H. P., Finn, R., Reljanovic, M., Lobisch, M., Schutte, K., Nehrdich, D., Tritschler, H., Mehnert, H., and Ziegler, D. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med 16(12), 1040-1043. 1999.
100. Ziegler D, Hanefeld M, Ruhnau KJ, Meissner HP, Lobisch M, Schutte K, Gries FA: Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 38:1425-1433, 1995
101. Reljanovic, M., Reichel, G., Rett, K., Lobisch, M., Schuette, K., Moller, W., Tritschler, H. J., and Mehnert, H. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res 31(3), 171-179. 1999.
102. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA: Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 21:114-121, 2004
103. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R: Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 29:2365-2370, 2006
104. Ziegler D, Low PA, Boulton AJ, Vinik AI, Freeman R, Samigullin R, Tritschler H, Munzel U, Maus J, Schuette K, Dyck PJ: Effect of 4-Year Antioxidant Treatment with alpha-Lipoic Acid in Diabetic Polyneuropathy: The NATHAN 1 Trial. (Abstract). Diabetes 56:A2, 2007
105. Vinik A, Bril V, Kempler P, Litchy W, Dyck P, Tesfaye S, Price K, Bastyr E, for the MBBQ Study: Treatment of symptomatic diabetic peripheral neuropathy with protein kinase CB inhibitor ruboxistaurin mesylate during a 1-year randomized, placebo-controlled, double-blind clinical trial. Clinical Therapeutics 27:1164-1180s, 2005
106. Vinik AI, Bril V, Litchy WJ, Price KL, Bastyr EJ, III: Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy. Muscle Nerve 2005
107. Pittenger G, Vinik A: Nerve growth factor and diabetic neuropathy. Exp Diabesity Res 4:271-285, 2003
108. Vinik AI: Treatment of diabetic polyneuropathy (DPN) with recombinant human nerve growth factor (rhNGF) (Abstract). Diabets 48 [Suppl 1]:A54-A55, 1999
109. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM: Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154:355-363, 1999
110. Tam J, Rosenberg L, Maysinger D: INGAP peptide improves nerve function and enhances regeneration in streptozotocin-induced diabetic C57BL/6 mice. FASEB J 18:1767-1769, 2004
111. Granberg V, Ejskjaer N, Peakman M, Sundkvist G: Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy. Diabetes Care 28:1959-1964, 2005
112. Vinik AI, Anandacoomaraswamy D, Ullal J: Antibodies to Neuronal Structures: Innocent bystanders or neurotoxins? Diabetes Care 28:2067-2072, 2005
113. Bays-Smith MG, Max MB, Muir J, Kingman A: Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design. Pain 60:267-274, 1995
114. Rains C, Bryson HM: Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 7:317-328, 1995
115. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S: Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116:109-118, 2005
116. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U: Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110:628-638, 2004
117. Vinik AI, Tuchman M, Safirstein B, Corder C, Kirby L, Wilks K, Quessy S, Blum D, Grainger J, White J, Silver M: Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain 128:169-179, 2007
118. Said G, Bigo A, Ameri A, Gayno JP, Elgrably F, Chanson P, Slama G: Uncommon early-onset neuropathy in diabetic patients. J Neurol 245:61-68, 1998
119. Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB: High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 48:1212-1218, 1997
120. Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Sachdeo R, Siu CO, Karmin M: Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 50:1842-1846, 1998
121. Jarvis B, Coukell AJ: Mexiletine. A review of its therapeutic use in painful diabetic neuropathy. Drugs 56:691-707, 1998
122. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DJ, Loeser JD, Max MB, Saltarelli M, Schmader KE, Stein C, Thompson D, Turk DC, Wallace MS, Watkins LR, Weinstein SM: Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60:1524-1534, 2003
123. Sindrup S, Gram L, Brosen K: The selective serotonin reuptake inhibitor paroxetine is effective in treatment of diabetic neuropathy symptoms. Pain 42:144, 1990
124. Max M, Lynch S, Muir J: Effects of desipramine, amitryptiline and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250-1256, 1992
125. Raskin J, Wang F, Pritchett YL, Goldstein DJ: Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study. Pain Med 7:373-385, 2006
126. Rowbotham MC, Goli V, Kunz NR, Lei D: Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 110:697-706, 2004
127. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A: Anticonvulsant drugs for management of pain: a systematic review. BMJ 311:1047-1052, 1995
128. Gorson KC, Schott C, Herman R, Ropper AH, Rand WM: Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry 66:251-252, 1999
129. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E: Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 280:1831-1836, 1998
130. DeToledo JC, Toledo C, DeCerce J, Ramsay RE: Changes in body weight with chronic, high-dose gabapentin therapy. Ther Drug Monit 19:394-396, 1997
131. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M: Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 115:254-263, 2005
132. Richter RW, Portenoy R, Sharma U, LaMoreaux L, Bockbrader H, Knapp LE: Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 6:253-260, 2005
133. Frampton JE, Scott LJ: Pregabalin: in the treatment of painful diabetic peripheral neuropathy. Drugs 64:2813-2820, 2004
134. Tarride JE, Gordon A, Vera-Llonch M, Dukes E, Rousseau C: Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective. Clin Ther 28:1922-1934, 2006
135. rice A, Barlow P, Pittenger G, Simmons K, Vinik A: Topiramate Improves Skin Blood Flow, Epidermal Nerve Fiber Morphology, Neuropathy and the Metabolic Syndrome in Patients with Diabetes (Abstract). Lancet Neurology 2006
136. Vinik A: CLINICAL REVIEW: Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocrinol Metab 90:4936-4945, 2005
137. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL: Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352:1324-1334, 2005
138. Vinik EJ, Hayes RP, Oglesby A, Bastyr E, Barlow P, Ford-Molvik SL, Vinik AI: The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther 7:497-508, 2005
139. Cavanagh PR, Derr JA, Ulbrecht JS, Maser RE, Orchard TJ: Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus. Diabet Med 9:469-474, 1992
140. Liu-Ambrose T, Khan KM, Eng JJ, Janssen PA, Lord SR, McKay HA: Resistance and agility training reduce fall risk in women aged 75 to 85 with low bone mass: a 6-month randomized, controlled trial. J Am Geriatr Soc 52:657-665, 2004
141. Somers DL, Somers MF: Treatment of neuropathic pain in a patient with diabetic neuropathy using transcutaneous electrical nerve stimulation applied to the skin of the lumbar region. Phys Ther 79:767-775, 1999
142. Cornblath DR, Vinik A, Feldman E, Freeman R, Boulton AJ: Surgical decompression for diabetic sensorimotor polyneuropathy. Diabetes Care 30:421-422, 2007
143. Vinik, A. I., Maser, R. E., Mitchell, B. D., and Freeman, R. Diabetic Autonomic Neuropathy. Diabetes Care 26(5), 1553-1579. 2003.
144. Pfeifer MA, Weinberg CR, Cook DL, Reenan A, Halter JB, Ensinck JW: Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 7:447-453, 1984
145. Stansberry KB, Hill MA, Shapiro SA, McNitt PM, Bhatt BA, Vinik AI: Impairment of peripheral blood flow responses in diabetes resembles an enhanced aging effect. Diabetes Care 20:1711-1716, 1997
146. Stansberry KB, Shapiro SA, Hill MA, McNitt PM, Meyer MD, Vinik AI: Impaired peripheral vasomotion in diabetes. Diabetes Care 19:715-721, 1996
147. Stansberry KB: Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes. Diabetes Care 22:1549-1554, 1999
148. Haak ES, Usadel KH, Kohleisen M, Yilmaz A, Kusterer K, Haak T: The effect of alpha-lipoic on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy. Microvasc Res 58:28-34, 1999
149. Ziegler D: Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metabolism Rev 10:339-383, 1994
150. Valensi P: Diabetic autonomic neuropathy: what are the risks? Diabets Metab 24:66-72, 1998
151. Mancia G, Paleari F, Parati G: Early diagnosis of diabetic autonomic neuropathy: present and future approaches. Diabetologia 40:482-484, 1997
152. Vinik AI, Maser RE, Nakave AA: Diabetic Cardiovascular Autonomic Nerve Dysfunction. Endocrine Today 2007
153. Karamitsos DT, Didangelos TP, Athyros VG, Kontopoulos AG: The natural history of recently diagnosed autonomic neuropathy over a period of 2 years. Diabetes Res Clin Pract 42:55-63, 1998
154. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE: Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects: The DIAD study. Diabetes Care 27:1954-1961, 2004
155. Ziegler D, Gries FA: Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 46 [Suppl 2]:S62-S66, 1997
156. Athyros VG, Didangelos TP, Karamitsos DT, Papageorgiou AA, Boudoulas H, Kontopoulos AG: Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy. Acta Cardiol 53:201-209, 1998
157. Gaede P, Vedel P, Parving HH, Pedersen O: Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomized study. Lancet 353:617-622, 1999
158. Malmberg K, Norhammar A, Wedel H, Ryden L: Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626-2632, 1999
159. Kendall DM, Rooney DP, Smets YF, Salazar Bolding L, Robertson RP: Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes 46:249-257, 1997
160. Burger AJ, Weinrauch LA, D'Elia JA, Aronson D: Effects of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. Am J Cardiol 84:687-691, 1999
161. Laederach-Hofmann K, Weidmann P, Ferrari P: Hypovolemia contributes to the pathogenesis of orthostatic hypotension in patients with diabetes mellitus. Am J Med 106:50-58, 1999
162. Denq JC, Opfer-Gehrking TL, Giuliani M, Felten J, Convertino VA, Low PA: Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clin Auton Res 7:321-326, 1997
163. Annese V, Bassotti G, Caruso N, De Cosmo S, Gabbrielli A, Modoni S, Frusciante V, Andriulli A: Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol 29:171-177, 1999
164. Melga P, Mansi C, Ciuchi E, Giusti R, Sciaba L, Prando R: Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis. Diabetes Care 20:55-58, 1997
165. Stacher G, Schernthaner G, Francesconi M, Kopp HP, Bergmann H, Stacher-Janotta G, Weber U: Cisapride versus Placebo for 8 weeks on glycemic control and gastric emptying in insulin-dependent diabetes: a double blind cross-over trial. J Clin Endocrinol Metab 84:2357-2362, 1999
166. Barone JA: Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann Pharmacother 33:429-440, 1999
167. Silvers D, Kipnes M, Broadstone V, Patterson D, Quigley EM, McCallum R, Leidy NK, Farup C, Liu Y, Joslyn A: Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group. Clin Ther 20:438-453, 1998
168. Erbas T, Varoglu E, Erbas B, Tastekin G, Akalin S: Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis. Diabetes Care 16:1511-1514, 1993
169. Abell TL, Bernstein RK, Cutts T, Farrugia G, Forster J, Hasler WL, McCallum RW, Olden KW, Parkman HP, Parrish CR, Pasricha PJ, Prather CM, Soffer EE, Twillman R, Vinik AI: Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 18:263-283, 2006
170. Vinik AI, Richardson D: Erectile Dysfunction in Diabetes. Diabetes Reviews 6:16-33, 1998
171. Vinik AI, Richardson D: Erectile Dysfunction in Diabetes:Pills for Penile Failure. Clinica Diabetes 16:108-119, 1998
172. Rendell MS, Rajfer J, Wicker PA, Smith MD: Sildenafil Diabetes Study Group. Sildenafil for treatment of erectile dysfunction in men with diabetes: a readomized controlled trial. JAMA 281:421-426, 1999
173. Boulton AJ, Selam JL, Sweeney M, Ziegler D: Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus. Diabetologia 44:1296-1301, 2001
174. Saenz de Tejada I, Anglin G, Knight JR, Emmick JT: Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care 25:2159-2164, 2002
175. Goldstein I, Young JM, Fischer J, Bangerter K, Segerson T, Taylor T: Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care 26:777-783, 2003
176. Enzlin, P., Mathieu, C., Vanderschueren, D., and Demyttenaere, K. Diabetes mellitus and female sexuality: a review of 25 years' research. Diabet Med 15(10), 809-815. 1998.
177. Shaw JE, Abbott CA, Tindle K, Hollis S, Boulton A: A randomised controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating. Diabetologia 40:299-301, 1997
178. Edick CM: Oral glycopyrrolate for the treatment of diabetic gustatory sweating. Ann Pharmacother 39:1760, 2005
179. Meyer C, Hering BJ, Grossmann R, Brandhorst H, Brandhorst D, Gerich J, Federlin K, Bretzel RG: Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with long-standing type I diabetes mellitus. Transplantation 66:233-240, 1998
180. Vinik A: Diagnosis and Management of Diabetic Neuropathy. Clinics in Geriatric Medicine 15:293-319, 1999
181. Shaw JE, Parker R, Hollis S, Gokal R, Boulton A: Gustatory sweating in diabetes mellitus. Diabet Med 13:1033-1037, 1996